Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin

被引：4
|
作者：
Bani-Sadr, Firouze [1 ]
Goderel, Isabelle [1 ]
Lapidus, Nathanael [1 ]
Driss, Henda [1 ]
Simon, Anne
Rosenthal, Eric [2 ]
Morand, Patrice [3 ]
Lunel-Fabiani, Francoise [5 ]
Pol, Stanislas [4 ]
Cacoub, Patrice
Perronne, Christian [6 ]
Carrat, Fabrice [1 ]
机构：
[1] Univ Paris 06, E Hosp Grp Univ, INSERM, U 707, F-75252 Paris 05, France
[2] Archet Hosp, Nice, France
[3] Grenoble Univ Hosp, Grenoble, France
[4] W Hosp Grp Univ, INSERM, U370, Paris, France
[5] Med Fac Angers, Angers, France
[6] Univ Versailles, Raymond Poincare Univ Hosp, Garches, France
来源：
AIDS | 2008年 / 22卷 / 11期
关键词：
D O I：
10.1097/QAD.0b013e328305bd8d
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1385 / 1387
页数：3
相关论文
共 50 条
  • [1] Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus-coinfected patients treated with interferon plus ribavirin
    Bani-Sadr, F.
    Goderel, I.
    Penalba, C.
    Billaud, E.
    Doll, J.
    Welker, Y.
    Cacoub, P.
    Pol, S.
    Perronne, C.
    Carrat, F.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (09) : 639 - 644
  • [2] Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: Analysis of risk factors
    Bani-Sadr, Firouze
    Lapidus, Nathanael
    Bedossa, Pierre
    De Boever, Corinne Merle
    Perronne, Christian
    Halfon, Philippe
    Pol, Stanislas
    Carrat, Fabrice
    Cacoub, Patrice
    CLINICAL INFECTIOUS DISEASES, 2008, 46 (05) : 768 - 774
  • [3] Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy
    Bani-Sadr, F
    Carrat, F
    Pol, S
    Hor, R
    Rosenthal, E
    Goujard, C
    Morand, P
    Lunel-Fabiani, F
    Salmon-Ceron, D
    Piroth, L
    Pialoux, G
    Bentata, M
    Cacoub, P
    Perronne, C
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (01) : 47 - 52
  • [4] Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus-Coinfected Patients with Advanced Immunosuppression
    Mira, Jose A.
    Gutierrez-Valencia, Alicia
    Gil, Ignacio De los Santos
    Merino, Dolores
    Rivero, Antonio
    Rios-Villegas, Maria J.
    Delgado, Marcial
    Gonzalez-Serrano, Mercedes
    Collado, Antonio
    Torres-Tortosa, Manuel
    Omar, Mohamed
    Angel Lopez-Ruz, Miguel
    Macias, Juan
    Arponen, Sari
    Pineda, Juan A.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (08) : E84 - E91
  • [5] Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus-Coinfected Patients With Compensated Liver Cirrhosis
    Mira, Jose A.
    Garcia-Rey, Silvia
    Rivero, Antonio
    de los Santos-Gil, Ignacio
    Lopez-Cortes, Luis F.
    Giron-Gonzalez, Jose A.
    Tellez, Francisco
    Marquez, Manuel
    Merino, Dolores
    Rios-Villegas, Maria J.
    Macias, Juan
    Rivero-Juarez, Antonio
    Pineda, Juan A.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (12) : 1719 - 1726
  • [6] Predictive value of early virologic response in HIV/hepatitis C virus-coinfected patients treated with an interferon-based regimen plus ribavirin
    Laguno, Montserrat
    Larrousse, Maria
    Murillas, Javier
    Blanco, Jose Luis
    Leon, Agathe
    Milinkovic, Ana
    Lonca, Montserrat
    Martinez, Esteban
    Sanchez-Tapias, Jose Maria
    de Lazzari, Elisa
    Gatell, Josep Ma
    Costa, Josep
    Mallolas, Josep
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 44 (02) : 174 - 178
  • [7] Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients
    Bedimo, Roger
    Kang, Minhee
    Tebas, Pablo
    Overton, Edgar T.
    Hollabaugh, Kimberly
    McComsey, Grace
    Bhattacharya, Debika
    Evans, Christopher
    Brown, Todd T.
    Taiwo, Babafemi
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 (04) : 325 - 328
  • [8] Prevalence of risk factors for hepatitis C virus in HIV-infected and HIV/hepatitis C virus-coinfected patients
    Bollepalli, Srigayatri
    Mathieson, Kathleen
    Bay, Curt
    Hillier, Amy
    Post, John
    Van Thiel, David H.
    Nadir, Abdul
    SEXUALLY TRANSMITTED DISEASES, 2007, 34 (06) : 367 - 370
  • [9] Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus-Coinfected Patients With Compensated Cirrhosis
    Mira, Jose A.
    Rivero-Juarez, Antonio
    Lopez-Cortes, Luis F.
    Giron-Gonzalez, Jose A.
    Tellez, Francisco
    de los Santos-Gil, Ignacio
    Macias, Juan
    Merino, Dolores
    Marquez, Manuel
    Rios-Villegas, Maria J.
    Gea, Isabel
    Merchante, Nicolas
    Rivero, Antonio
    Torres-Cornejo, Almudena
    Pineda, Juan A.
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (11) : 1646 - 1653
  • [10] Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients
    Valerio, Laure
    Yazdanpanah, Yazdan
    Poizot-Martin, Isabelle
    Rosenthal, Eric
    Marimoutou, Catherine
    Gastaut, Jean-Albert
    Tran, Albert
    Dellamonica, Pierre
    Freedberg, Kenneth A.
    Pradier, Christian
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (01) : 50 - 55
12345